SCPH - scPharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development15,94814,33111,8568,267
Selling General and Administrative13,7199,1056,0542,577
Non Recurring----
Total Operating Expenses29,66723,43617,91010,844
Operating Income or Loss-29,667-23,436-17,910-10,844
Income from Continuing Operations
Total Other Income/Expenses Net224-381-6,467326
Earnings Before Interest and Taxes-29,667-23,436-17,910-10,844
Interest Expense-1,432-797-6,512-6,512
Income Before Tax-29,443-23,817-24,377-10,518
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-29,443-23,817-24,377-10,518
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-29,443-23,817-24,377-10,518
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-29,443-23,817-24,377-10,518